Revision history of "Development of a CHO cell-based and innovative expressive system of biosimilar production platform and preclinical and clinical development of a biosimilar drug based on the Fab fragment" (Q78867)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 October 2024

  • curprev 05:5405:54, 13 October 2024DG Regio talk contribs 96,527 bytes +12 Changed label, description and/or aliases in pt
  • curprev 05:5405:54, 13 October 2024DG Regio talk contribs 96,515 bytes −15 Set a claim value: summary (P836): Número de referência do programa de ajuda: SA.41471(2015/X) Objetivo do auxílio público: Artigo 25.o do Regulamento (CE) n.o 651/2014, de 17 de junho de 2014, que declara certos tipos de auxílio compatíveis com o mercado interno, em aplicação dos artigos 107.o e 108.o do Tratado (JO L EU L 187/1 de 26.6.2014). O objetivo do projeto é desenvolver uma tecnologia de produção inovadora baseada em células CHO e um sistema inovador de expressão de um medi...

20 March 2024

12 January 2024

11 June 2023

24 May 2023

2 March 2023

  • curprev 22:2322:23, 2 March 2023DG Regio talk contribs 93,775 bytes −6 Changed label, description and/or aliases in da, it, sk, fi, cs, lv, sv, ga, de, ro, el, bg, pt, sl, mt, et, fr, lt, hu, nl, es, hr, and other parts

25 October 2022

20 October 2022

25 July 2022

  • curprev 21:1321:13, 25 July 2022DG Regio talk contribs 92,107 bytes +60,157 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

15 January 2022

16 December 2021

7 December 2021

30 November 2021

  • curprev 14:2514:25, 30 November 2021DG Regio talk contribs 18,681 bytes +3,084 Created claim: summary (P836): Reference_Aid_programme: SA.41471(2015/X) But_public_aid: Article 25 du règlement (CE) no 651/2014 du 17 juin 2014 déclarant certaines catégories d’aides compatibles avec le marché intérieur en application des articles 107 et 108 du traité (JO URZ. EU L 187/1 du 26.6.2014). L’objectif du projet est de développer une technologie de production innovante basée sur les cellules CHO et un système innovant d’expression du biosimilaire au ranibizumab u...
  • curprev 14:2514:25, 30 November 2021DG Regio talk contribs 15,597 bytes +243 Changed label, description and/or aliases in fr: translated_label

29 October 2020

14 October 2020

  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 15,794 bytes +246 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 15,548 bytes −267 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 15,815 bytes +2,864 Created claim: summary (P836): Reference number of the aid programme: SA.41471(2015/X) Purpose of public aid: Article 25 of EC Regulation No 651/2014 of 17 June 2014 declaring certain types of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L. I'm sorry. EU L 187/1 of 26.06.2014). The aim of the project is to develop an innovative production technology based on CHO cells and an innovative system of expression of a biosimila...
  • curprev 10:3110:31, 14 October 2020DG Regio talk contribs 12,951 bytes −2,396 Removed claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The project aims to develop an innovative production technology based on a CHO cell and an innovative system for the expression of a biosimilar to ranbizumab...

25 September 2020

23 September 2020

15 July 2020

9 June 2020

6 June 2020

26 March 2020

4 March 2020

  • curprev 09:3109:31, 4 March 2020DG Regio talk contribs 13,627 bytes +2,396 Created claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The project aims to develop an innovative production technology based on a CHO cell and an innovative system for the expression of a biosimilar to ranbizumab f...

18 February 2020

8 February 2020

31 January 2020

13 January 2020